Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Pichler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 2, 2018
[Controversies in prisma pretreatment prior to squint surgery]Ulrike Pichler
Immunotherapy|November 29, 2013
Recombinant allergens for pollen immunotherapyMichael Wallner, Ulrike Pichler, Fatima Ferreira
Strabismus|December 12, 2024
Occlusion with high plus contact lenses in the treatment of strabismic amblyopia - a case seriesUlrike Pichler, Lisa Gabriela Schneebauer, Verena Schoßleitner, et al.
Acta Ophthalmologica|August 25, 2021
A comparative study of various prism adaptation forms in the surgical management of esophoriaUlrike Pichler, Elke Schmidbauer, Philipp Hermann, et al.
Biomed Research International|November 1, 2013
The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse modelUlrike Pichler, Claudia Asam, Richard Weiss, et al.
Plos One|March 2, 2011
Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradomeMatthias Egger, Alexander Jürets, Michael Wallner, et al.
Blood|February 7, 2014
Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cellsSebastian W Hofbauer, Peter W Krenn, Sylvia Ganghammer, et al.
The Journal of Allergy and Clinical Immunology|March 23, 2011
Reshaping the Bet v 1 fold modulates T(H) polarizationMichael Wallner, Michael Hauser, Martin Himly, et al.
Plos One|May 16, 2015
Pectate lyase pollen allergens: sensitization profiles and cross-reactivity patternUlrike Pichler, Michael Hauser, Martin Wolf, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 2, 2018
[Controversies in prisma pretreatment prior to squint surgery]Ulrike Pichler
Immunotherapy|November 29, 2013
Recombinant allergens for pollen immunotherapyMichael Wallner, Ulrike Pichler, Fatima Ferreira
Strabismus|December 12, 2024
Occlusion with high plus contact lenses in the treatment of strabismic amblyopia - a case seriesUlrike Pichler, Lisa Gabriela Schneebauer, Verena Schoßleitner, et al.
Acta Ophthalmologica|August 25, 2021
A comparative study of various prism adaptation forms in the surgical management of esophoriaUlrike Pichler, Elke Schmidbauer, Philipp Hermann, et al.
Biomed Research International|November 1, 2013
The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse modelUlrike Pichler, Claudia Asam, Richard Weiss, et al.
Plos One|March 2, 2011
Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradomeMatthias Egger, Alexander Jürets, Michael Wallner, et al.
Blood|February 7, 2014
Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cellsSebastian W Hofbauer, Peter W Krenn, Sylvia Ganghammer, et al.
The Journal of Allergy and Clinical Immunology|March 23, 2011
Reshaping the Bet v 1 fold modulates T(H) polarizationMichael Wallner, Michael Hauser, Martin Himly, et al.
Plos One|May 16, 2015
Pectate lyase pollen allergens: sensitization profiles and cross-reactivity patternUlrike Pichler, Michael Hauser, Martin Wolf, et al.
Pageof 1